Kelly Lawrence W & Associates’s Thermo Fisher Scientific TMO Stock Holding History

Kelly Lawrence W & Associates’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$251K	Hold	500	–	–	0.05%	77
2026 Q1	$246K	Hold	500	–	–	0.07%	76
2025 Q4	$290K	Hold	500	–	–	0.07%	72
2025 Q3	$243K	Hold	500	–	–	0.06%	74
2025 Q2	$203K	Hold	500	–	–	0.05%	81
2025 Q1	$249K	Hold	500	–	–	0.06%	73
2024 Q4	$260K	Buy	500 +170	+52%	+$93.5K	0.06%	73
2024 Q3	$204K	Sell	330 -8	-2%	-$4.74K	0.05%	87
2024 Q2	$187K	Hold	338	–	–	0.04%	86
2024 Q1	$196K	Buy	338 +8	+2%	+$4.49K	0.04%	79
2023 Q4	$175K	Hold	330	–	–	0.04%	84
2023 Q3	$167K	Buy	+330	New	+$176K	0.04%	81

Other funds holding TMO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Kelly Lawrence W & Associates's TMO Position: Q2 2026 in Review

Kelly Lawrence W & Associates held its Thermo Fisher Scientific (TMO) position steady in Q2 2026 at 500 shares worth $251K. The position accounts for 0.05% of the portfolio, ranked #77.

Kelly Lawrence W & Associates first reported a position in TMO in Q3 2023 and has held it in 12 quarters since. The position peaked at $290K in Q4 2025. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

Kelly Lawrence W & Associates held 500 shares of Thermo Fisher Scientific worth $251K as of Q2 2026.
Kelly Lawrence W & Associates left its Thermo Fisher Scientific share count unchanged in Q2 2026.
Thermo Fisher Scientific made up 0.05% of Kelly Lawrence W & Associates's portfolio in Q2 2026, its #77 holding.
Kelly Lawrence W & Associates first reported a position in Thermo Fisher Scientific in Q3 2023 and has held it in 12 quarters since.
Kelly Lawrence W & Associates's Thermo Fisher Scientific position peaked at $290K in Q4 2025.
2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Kelly Lawrence W & Associates's 13F filing for Q2 2026, filed 14 Aug 2026.